Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001723643-25-000013
Filing Date
2025-09-26
Accepted
2025-09-26 16:01:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6168
2 exhibit1.htm EX-1 2785
  Complete submission text file 0001723643-25-000013.txt   10729
Mailing Address 280 PARK AVENUE, 5TH FLOOR WEST NEW YORK NY 10017
Business Address 280 PARK AVENUE, 5TH FLOOR WEST NEW YORK NY 10017 6465610434
Shay Capital LLC (Filed by) CIK: 0001723643 (see all company filings)

EIN.: 822647087 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address YALELAAN 62 UTRECHT Netherlands
Business Address YALELAAN 62 UTRECHT Netherlands 31 6 3000 3035
LAVA Therapeutics NV (Subject) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92425 | Film No.: 251350368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)